Cinemark Seen Benefiting From Stronger Film Slate, Pricing Gains, Wedbush Says

MT Newswires Live
05/04

Cinemark (CNK) is positioned to benefit from a more consistent film release slate over the coming quarters, along with ongoing gains in pricing, premium format adoption and theater investment initiatives, Wedbush Securities said in a Monday note.

The analysts said Cinemark delivered strong Q1 results with revenue, adjusted EBITDA, and earnings per share all exceeding expectations. The performance was driven by robust domestic box office trends, higher attendance and improved ticket pricing.

Wedbush highlighted strong concessions performance, including record domestic food and beverage per-cap spending, supported by pricing actions and operational efficiencies. The note also pointed to steady market share, a strong loyalty program and expanding alternative content offerings.

The company can benefit from investments in premium seating, laser projection and IMAX expansion. It also sees upside from new builds and potential acquisitions. Shareholder returns through dividends and buybacks remain a key part of the story and a stronger film slate should support performance over the rest of the year, according to the note.

Wedbush maintained its outperform rating on the stock with a price target of $37.

Shares of Cinemark were up 1.6% in Monday trading.

Price: 28.07, Change: +0.45, Percent Change: +1.63

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10